Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 86
Filtrar
3.
Proc Natl Acad Sci U S A ; 121(17): e2307216121, 2024 Apr 23.
Artículo en Inglés | MEDLINE | ID: mdl-38621126

RESUMEN

Uncontrolled fires place considerable burdens on forest ecosystems, compromising our ability to meet conservation and restoration goals. A poor understanding of the impacts of fire on ecosystems and their biodiversity exacerbates this challenge, particularly in tropical regions where few studies have applied consistent analytical techniques to examine a broad range of ecological impacts over multiyear time frames. We compiled 16 y of data on ecosystem properties (17 variables) and biodiversity (21 variables) from a tropical peatland in Indonesia to assess fire impacts and infer the potential for recovery. Burned forest experienced altered structural and microclimatic conditions, resulting in a proliferation of nonforest vegetation and erosion of forest ecosystem properties and biodiversity. Compared to unburned forest, habitat structure, tree density, and canopy cover deteriorated by 58 to 98%, while declines in species diversity and abundance were most pronounced for trees, damselflies, and butterflies, particularly for forest specialist species. Tracking ecosystem property and biodiversity datasets over time revealed most to be sensitive to recurrent high-intensity fires within the wider landscape. These megafires immediately compromised water quality and tree reproductive phenology, crashing commercially valuable fish populations within 3 mo and driving a gradual decline in threatened vertebrates over 9 mo. Burned forest remained structurally compromised long after a burn event, but vegetation showed some signs of recovery over a 12-y period. Our findings demonstrate that, if left uncontrolled, fire may be a pervasive threat to the ecological functioning of tropical forests, underscoring the importance of fire prevention and long-term restoration efforts, as exemplified in Indonesia.


Asunto(s)
Mariposas Diurnas , Incendios , Animales , Ecosistema , Suelo , Bosques , Árboles , Biodiversidad
6.
J Cardiovasc Pharmacol ; 83(1): 126-130, 2024 Jan 01.
Artículo en Inglés | MEDLINE | ID: mdl-38180458

RESUMEN

ABSTRACT: Central sleep apnea (CSA) is common in patients with heart failure. Recent studies link ticagrelor use with CSA. We aimed to evaluate CSA prevalence in patients with coronary heart disease (CHD) and whether ticagrelor use is associated with CSA. We reviewed consecutive patients with CHD who underwent a polysomnography (PSG) test over a 5-year period from 3 sleep centers. We sampled patients who were on ticagrelor or clopidogrel during a PSG test at a 1:4 ticagrelor:clopidogrel ratio. Patients with an active opioid prescription during PSG test were excluded. Age, left ventricle (LV) dysfunction, and P2Y12 inhibitor use were included in a multivariate logistic regression. A total of 135 patients were included with 26 on ticagrelor and 109 on clopidogrel (age 64.1 ± 11.4, 32% male). High CSA burden (12%) and strict CSA (4.4%) were more common in patients on ticagrelor than in those on clopidogrel (27% vs. 8.3% and 10.0% vs. 1.8%). Ticagrelor use (vs. clopidogrel) was associated with high CSA burden (OR 3.53, 95% CI 1.04-12.9, P = 0.039) and trended toward significance for strict CSA (OR 6.32, 95% CI 1.03-51.4, P = 0.052) when adjusting for age and LV dysfunction. In an additional analysis also adjusting for history of atrial fibrillation, ticagrelor use and strict CSA became significantly associated (OR 10.0, 95% CI 1.32-117, P = 0.035). CSA was uncommon in patients with CHD undergoing sleep studies. Ticagrelor use (vs. clopidogrel) was associated with high CSA burden and trended toward significance for strict CSA.


Asunto(s)
Enfermedad Coronaria , Apnea Central del Sueño , Humanos , Masculino , Persona de Mediana Edad , Anciano , Femenino , Apnea Central del Sueño/inducido químicamente , Apnea Central del Sueño/diagnóstico , Apnea Central del Sueño/epidemiología , Clopidogrel , Ticagrelor/efectos adversos , Analgésicos Opioides , Enfermedad Coronaria/diagnóstico , Enfermedad Coronaria/tratamiento farmacológico , Enfermedad Coronaria/epidemiología
7.
J Clin Sleep Med ; 20(1): 127-134, 2024 Jan 01.
Artículo en Inglés | MEDLINE | ID: mdl-37772707

RESUMEN

Obstructive sleep apnea (OSA) is the most common respiratory sleep disorder in the United States in preschool and school-aged children. In an effort to continue addressing gaps and variations in care in this patient population, the American Academy of Sleep Medicine (AASM) Quality Measures Task Force performed quality measure maintenance on the Quality Measures for the Care of Pediatric Patients with Obstructive Sleep Apnea (originally developed in 2015). The Quality Measures Task Force reviewed the current medical literature, including updated clinical practice guidelines and systematic literature reviews, existing pediatric OSA quality measures, and performance data highlighting remaining gaps or variations in care since implementation of the original quality measure set to inform any potential revisions to the quality measures. These revised quality measures have been implemented in the AASM Sleep Clinical Data Registry (Sleep CDR) to capture performance data and encourage continuous quality improvement, specifically in outcomes associated with diagnosing and managing OSA in the pediatric population. CITATION: Lloyd RM, Crawford T, Donald R, et al. Quality measures for the care of pediatric patients with obstructive sleep apnea: 2023 update after measure maintenance. J Clin Sleep Med. 2024;20(1):127-134.


Asunto(s)
Indicadores de Calidad de la Atención de Salud , Apnea Obstructiva del Sueño , Preescolar , Humanos , Niño , Estados Unidos , Apnea Obstructiva del Sueño/diagnóstico , Apnea Obstructiva del Sueño/terapia , Sueño , Mejoramiento de la Calidad , Frecuencia Respiratoria
9.
Am J Med Sci ; 366(4): 270-277, 2023 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-37454928

RESUMEN

BACKGROUND: Sleep disturbances in patients with end-stage renal disease (ESRD) are common and more prevalent than in the general population. This study aims to assess the demographic and clinical risk factors for the diagnosis of sleep disorders in ESRD patients. METHODS: This study is a retrospective analysis of the United States Renal Data System (USRDS) to evaluate risk factors for the diagnosis of sleep disorders, including hypersomnolence, insomnia, restless leg syndrome (RLS), or obstructive or central sleep apnea (OSA/CSA). All ESRD subjects enrolled in the USRDS between 2004-2015 were eligible for inclusion. The risk factors analyzed were age, race, sex, ethnicity, access type, dialysis modality, and the Charlson Comorbidity Index (CCI). All statistical analysis was performed using SAS 9.4, and statistical significance was assessed using an alpha level of 0.05. Descriptive statistics on all variables overall and by each sleep diagnosis were determined. RESULTS: Increasing age, black race, other race, and Hispanic ethnicity were associated with decreased risk of each sleep diagnosis while CCI was associated with increased risk. Females were at increased risk of RLS and insomnia while males were at increased risk of OSA/CSA. Catheter and graft access decreased risk of RLS but increased risk of insomnia compared to AVF access. Catheter access increased risk of OSA/CSA compared to graft access. Hemodialysis increased risk of OSA/CSA compared to peritoneal dialysis. CONCLUSIONS: Some ESRD patients are at an increased risk for diagnosis of sleep disorders based on age, race, sex, comorbid health conditions, and dialysis modality.

10.
ATS Sch ; 4(1): 96-97, 2023 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-37089673
11.
Environ Sci Technol ; 57(16): 6360-6372, 2023 04 25.
Artículo en Inglés | MEDLINE | ID: mdl-37036108

RESUMEN

Residential buildings provide unique conditions for opportunistic premise plumbing pathogen (OPPP) exposure via aerosolized water droplets produced by showerheads, faucets, and tubs. The objective of this review was to critically evaluate the existing literature that assessed the impact of potentially enhancing conditions to OPPP occurrence associated with residential plumbing and to point out knowledge gaps. Comprehensive studies on the topic were found to be lacking. Major knowledge gaps identified include the assessment of OPPP growth in the residential plumbing, from building entry to fixtures, and evaluation of the extent of the impact of typical residential plumbing design (e.g., trunk and branch and manifold), components (e.g., valves and fixtures), water heater types and temperature setting of operation, and common pipe materials (copper, PEX, and PVC/CPVC). In addition, impacts of the current plumbing code requirements on OPPP responses have not been assessed by any study and a lack of guidelines for OPPP risk management in residences was identified. Finally, the research required to expand knowledge on OPPP amplification in residences was discussed.


Asunto(s)
Agua Potable , Ingeniería Sanitaria , Abastecimiento de Agua , Vivienda , Microbiología del Agua
12.
Sleep Breath ; 27(5): 1917-1924, 2023 10.
Artículo en Inglés | MEDLINE | ID: mdl-36930416

RESUMEN

BACKGROUND: The impact of sleep disordered breathing (SDB) on heart failure (HF) is increasingly recognized. However, limited data exist in support of quantification of the clinical and financial impact of SDB on HF hospitalizations. METHODS: A sleep-heart registry included all patients who underwent inpatient sleep testing during hospitalization for HF at a single cardiac center. Readmission data and actual costs of readmissions were obtained from the institutional honest broker. Patients were classified based on the inpatient sleep study as having no SDB, obstructive sleep apnea (OSA), or central sleep apnea (CSA). Cumulative cardiac readmission rates and costs through 3 and 6 months post-discharge were calculated. Unadjusted and adjusted (age, sex, body mass index, and left ventricular ejection fraction) modeling of cost was performed. RESULTS: The cohort consisted of 1547 patients, 393 (25%) had no SDB, 438 (28%) had CSA, and 716 (46%) had OSA. Within 6 months of discharge, 195 CSA patients (45%), 264 OSA patients (37%), and 109 no SDB patients (28%) required cardiovascular readmissions. Similarly, 3- and 6-month mortality rates were higher in both SDB groups than those with no SDB. Both unadjusted and adjusted readmission costs were higher in the OSA and CSA groups compared to no SDB group at 3 and 6 months post-discharge with the CSA and OSA group costs nearly double (~ $16,000) the no SDB group (~ $9000) through 6 months. INTERPRETATION: Previously undiagnosed OSA and CSA are common in patients hospitalized with HF and are associated with increased readmissions rate and mortality.


Asunto(s)
Insuficiencia Cardíaca , Síndromes de la Apnea del Sueño , Apnea Central del Sueño , Apnea Obstructiva del Sueño , Humanos , Volumen Sistólico , Cuidados Posteriores , Función Ventricular Izquierda , Alta del Paciente , Síndromes de la Apnea del Sueño/diagnóstico , Síndromes de la Apnea del Sueño/terapia , Síndromes de la Apnea del Sueño/complicaciones , Apnea Obstructiva del Sueño/diagnóstico , Apnea Obstructiva del Sueño/epidemiología , Apnea Obstructiva del Sueño/terapia , Insuficiencia Cardíaca/complicaciones , Hospitalización
13.
J Investig Med ; 71(5): 465-470, 2023 06.
Artículo en Inglés | MEDLINE | ID: mdl-36945195

RESUMEN

Sleep apnea (SA) is highly prevalent in the end-stage renal disease (ESRD) population. However, the impact of SA on mortality in ESRD is unclear. This study investigates the relationship between SA and mortality in ESRD. The United States Renal Data System was queried in a retrospective cohort study to identify ESRD patients aged 18-100 years who initiated hemodialysis between 2005 and 2013. Diagnoses of SA and comorbidities were determined from International Classification of Disease-9 codes and demographic variables from Centers for Medicare and Medicaid Services Form-2728. Cox proportional hazards models were used to examine the association of SA with mortality controlling for multiple variables. Of 858,131 subjects meeting inclusion criteria, 587 were found to have central SA (CSA) and 22,724 obstructive SA (OSA). The SA cohort was younger and more likely to be male and Caucasian compared to the non-SA cohort, with more diagnoses of tobacco and alcohol use, hypertension, heart failure, and diabetes. Both CSA (adjusted hazard ratio (aHR) = 1.42, 95% confidence interval (CI): 1.29-1.56) and OSA (aHR = 1.35, 95% CI: 1.32-1.37) were associated with increased mortality. Other variables associated with increased mortality included age, dialysis initiation with a catheter or graft, alcohol use, hypertension, and cardiovascular disease. Factors associated with decreased mortality included female sex, black race, Hispanic ethnicity, diagnosis of heart failure or diabetes, and an ESRD etiology of glomerulonephritis or polycystic kidney disease. Since a diagnosis of either OSA or CSA increases mortality risk, early identification of SA and therapy in this ESRD population may improve survival.


Asunto(s)
Insuficiencia Cardíaca , Hipertensión , Fallo Renal Crónico , Síndromes de la Apnea del Sueño , Apnea Obstructiva del Sueño , Humanos , Anciano , Masculino , Femenino , Estados Unidos/epidemiología , Estudios Retrospectivos , Medicare , Fallo Renal Crónico/complicaciones , Fallo Renal Crónico/terapia , Síndromes de la Apnea del Sueño/complicaciones , Síndromes de la Apnea del Sueño/epidemiología , Diálisis Renal/efectos adversos , Factores de Riesgo , Hipertensión/complicaciones , Insuficiencia Cardíaca/complicaciones
14.
15.
Chest ; 161(5): 1330-1337, 2022 05.
Artículo en Inglés | MEDLINE | ID: mdl-34808108

RESUMEN

Central sleep apnea (CSA) frequently coexists with heart failure and atrial fibrillation and contributes to cardiovascular disease progression and mortality. A transvenous phrenic nerve stimulation (TPNS) system has been approved for the first time by the Food and Drug Administration for the treatment of CSA. This system, remede System (Zoll Medical, Inc.), is implanted during a minimally invasive outpatient procedure and has shown a favorable safety and efficacy profile. Currently, patient access to this therapy remains limited by the small number of specialized centers in the United States and the absence of a standard coverage process by insurers. Although a period of evaluation by insurers is expected for new therapies in their early stages, the impact on patients is particularly severe given the already limited treatment options for CSA. Implantation and management of this novel therapy require the establishment of a specialized multidisciplinary program as part of a sleep medicine practice and support from health care systems and hospitals. Several centers in the United States have been successful in building sustainable TPNS programs offering this novel therapy to their patients by navigating the current reimbursement environment. In this article, we review the background and efficacy data of TPNS and briefly address relevant aspects of the clinical activities involved in a TPNS program. The article presents the status of coverage and reimbursement for this novel therapy. We also discuss the current approach to obtaining reimbursement from third-party payors during this transitional period of evaluation by Medicare and other insurers.


Asunto(s)
Terapia por Estimulación Eléctrica , Apnea Central del Sueño , Anciano , Humanos , Medicare , Nervio Frénico , Resultado del Tratamiento , Estados Unidos
17.
J Arthroplasty ; 35(12): 3569-3574, 2020 12.
Artículo en Inglés | MEDLINE | ID: mdl-32694028

RESUMEN

BACKGROUND: Conversion total knee arthroplasty (TKA) in the presence of periarticular hardware can be associated with increased resource utilization, complications, and revisions. However, little guidance exists on the optimal approach to hardware removal. The purpose of this study is to compare outcomes of conversion TKA with hardware removal performed in either a staged or concurrent manner. METHODS: This is a retrospective study of 155 TKA operations performed with staged (45) or concurrent (110) removal of hardware at the time of TKA. Differences in patient data, case data, complications, reoperations, and revisions were evaluated. Subgroup comparisons of cases involving major hardware (plates, nails, rods), minor hardware (screws, buttons, wires), and tibial plates were performed. RESULTS: There were no differences in age, sex, body mass index, or comorbidities between patients who underwent staged or concurrent hardware removal. Rates of complications, reoperations, and revisions did not differ at multiple time points (90 days, 1 year, 2 years, 4 years). Patients who underwent staged hardware removal were more likely to have had prior surgery for fracture reconstruction (68% vs 33%, P < .001), to have had major hardware removed (84% vs 59%, P = .03), and were less likely to have had hardware removal performed through a single incision with TKA (50% vs 92%, P < .001). Subgroup analysis of major and minor hardware cases demonstrated comparable outcomes. CONCLUSION: There remains no established benefit to either a staged or concurrent approach to hardware removal at the time of TKA. This is true regardless of hardware burden. At this time, a case-by-case approach should be taken to conversion TKA in the presence of periarticular hardware.


Asunto(s)
Artroplastia de Reemplazo de Rodilla , Osteoartritis de la Rodilla , Artroplastia de Reemplazo de Rodilla/efectos adversos , Humanos , Osteoartritis de la Rodilla/cirugía , Reoperación , Estudios Retrospectivos , Tibia/cirugía
18.
J Arthroplasty ; 35(7S): S32-S36, 2020 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-32345566

RESUMEN

BACKGROUND: The economic effects of the COVID-19 crisis are not like anything the U.S. health care system has ever experienced. METHODS: As we begin to emerge from the peak of the COVID-19 pandemic, we need to plan the sustainable resumption of elective procedures. We must first ensure the safety of our patients and surgical staff. It must be a priority to monitor the availability of supplies for the continued care of patients suffering from COVID-19. As we resume elective orthopedic surgery and total joint arthroplasty, we must begin to reduce expenses by renegotiating vendor contracts, use ambulatory surgery centers and hospital outpatient departments in a safe and effective manner, adhere to strict evidence-based and COVID-19-adjusted practices, and incorporate telemedicine and other technology platforms when feasible for health care systems and orthopedic groups to survive economically. RESULTS: The return to normalcy will be slow and may be different than what we are accustomed to, but we must work together to plan a transition to a more sustainable health care reality which accommodates a COVID-19 world. CONCLUSION: Our goal should be using these lessons to achieve a healthy and successful 2021 fiscal year.


Asunto(s)
Betacoronavirus , Infecciones por Coronavirus , Procedimientos Quirúrgicos Electivos/economía , Articulaciones/cirugía , Pandemias , Neumonía Viral , Artroplastia , COVID-19 , Infecciones por Coronavirus/epidemiología , Atención a la Salud , Humanos , Procedimientos Ortopédicos , Neumonía Viral/epidemiología , SARS-CoV-2 , Telemedicina
19.
J Arthroplasty ; 33(3): 668-672, 2018 03.
Artículo en Inglés | MEDLINE | ID: mdl-29128235

RESUMEN

BACKGROUND: The purpose of our study is to examine post-operative opioid use in total hip arthroplasty (THA) and total knee arthroplasty (TKA) patients and describe factors associated with the need for refill prescriptions. METHODS: Using online prescription information, we calculated the number of filled prescriptions, total morphine equivalent dose (MED) and quantity of pills, and date of last opioid prescription (days) for 197 TKA and 186 THA patients. Patients were classified based on refill status. Opioid data were compared between TKA and THA patients. Relationships between comorbidities and refill status were examined. RESULTS: Number of prescriptions (P < .001), total quantity (P < .001) and MED (P < .001), and days on opioids (P < .001) were greater for TKA patients. TKA patients required more refills (P < .001) for a greater quantity of pills (P = .007). The presence of a comorbidity (P = .003) or anxiety/depression (P = .004) were correlated with refills for TKA patients only. A comorbidity increased the risk of refills by 3.1 times, while anxiety/depression had a 2.5 times greater risk of refills. CONCLUSION: Compared to THA patients, TKA patients were twice as likely to require refill opioid prescriptions and were prescribed a greater total MED for a longer period of time post-operatively. Patients undergoing TKA who present with a comorbidity or are currently being treated for anxiety or depression are more likely to require a refill.


Asunto(s)
Analgésicos Opioides/uso terapéutico , Artroplastia de Reemplazo de Cadera , Artroplastia de Reemplazo de Rodilla , Morfina/uso terapéutico , Prescripciones/estadística & datos numéricos , Anciano , Anciano de 80 o más Años , Ansiedad , Índice de Masa Corporal , Estudios de Cohortes , Comorbilidad , Recolección de Datos , Depresión , Femenino , Humanos , Masculino , Persona de Mediana Edad , Periodo Posoperatorio , Factores de Riesgo
20.
J Bone Joint Surg Am ; 99(21): e114, 2017 Nov 01.
Artículo en Inglés | MEDLINE | ID: mdl-29088046

RESUMEN

BACKGROUND: In 2017, approximately 90% of U.S. orthopaedic residents chose to participate in orthopaedic fellowships. The process of applying and interviewing for an orthopaedic fellowship is expensive and time-consuming for both orthopaedic residents and orthopaedic residency programs. Considerable physician man-hours are allocated to fellowship interviews and the match ranking process, and there are unintended consequences of time away from work for the resident and his or her training program. To reduce time and cost allocated to fellowship interviews, we implemented videoconference interviews for our adult reconstruction fellowship. The purpose of this article was to communicate the lessons that we learned about this innovation. METHODS: Candidates and faculty who participated in videoconference interviews for our adult reconstruction fellowship during 2015 through 2017 were surveyed to learn more about the utility and acceptance of videoconference interviewing. RESULTS: Eighty-five percent of the 47 videoconference interview candidates who responded to our survey believed that the videoconference interviews gave them a satisfactory understanding of our adult reconstruction fellowship; 85% of candidates stated that the fellowship manual and the videoconference interviews gave them a satisfactory understanding of our fellowship; 89% of candidates stated that the videoconference interview met their expectations; 85% of candidates believed that the videoconference interviews allowed them to present themselves to the program to their satisfaction; and 81% of candidates were comfortable ranking our program after the videoconference interviews. Furthermore, there was universal gratitude in the subjective comments for the convenience and low cost of the videoconference interviews. However, we are concerned that 15% of the candidates did not believe that they had the opportunity to present themselves to their satisfaction with videoconference interviews; 19% of applicants were not comfortable ranking our program after a videoconference interviews; 34% of videoconference interview candidates stated that the videoconference interviews had an unfavorable impact on their ranking of our program; and 30% of candidates believed that the videoconference interview was not a good format for fellowship interviews. CONCLUSIONS: This review presents what we learned about using videoconference interviews for evaluating and selecting adult reconstruction fellows. The role of videoconference interviews for selecting adult reconstruction fellows remains to be determined.


Asunto(s)
Becas , Entrevistas como Asunto/métodos , Ortopedia/educación , Selección de Personal/métodos , Comunicación por Videoconferencia , Humanos , Internado y Residencia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA